Home > Journals > Pediatric Education and Research

Pediatric Education and Research

Submit your article Read this Journals View all journals
Full Text (PDF)
Review Article

The Contribution of Dr. Steven E Lipshultz in Field of Pediatrics

Suryawanshi Rushikesh Giridhar, Kasumbiwal Ajay H, Lakhe Siddheshwar A, Pavani Kaithi

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.

Pediatric Education and Research 13(2 (Special Supplement -I)):p 255-257, July-December 2025. | DOI: 10.21088/per.2321.1644.13225.54

How Cite This Article:

Kasumbiwal Ajay H., Lakhe Siddheshwar A., Pavani Kaithi, et al. The Contribution of Dr. Steven E Lipshultz in Field of Pediatrics. Pediatr. Edu. Res. 2025; 13(2): 255-257.

Timeline

Received : December 11, 2025         Accepted : December 31, 2025          Published : December 31, 2025

Abstract

Dr. Steven E. Lipshultz is one of the most influential pediatricians and physicianscientists of modern medicine, globally recognized for pioneering research in pediatric cardiology, cardiomyopathy, cancer-therapy–related heart disease, HIV-related cardiac disorders, myocarditis, heart failure, Kawasaki disease, and long-term child health outcomes. His innovative contributions have transformed clinical practice and significantly improved survival and quality of life in children with chronic cardiac illness. Before his work, many childhood cancer survivors died due to delayed heart failure caused by anthracycline chemotherapy. Dr. Lipshultz discovered: • Dose-dependent cardiotoxicity • Late progressive cardiac dysfunction • Early markers for heart damage He established preventive monitoring strategies now used worldwide. Key Messages: Dr. Steven E. Lipshultz revolutionized pediatric cardiology by identifying, preventing, and treating life-threatening cardiac complications in children particularly those caused by cancer therapy, HIV infection, myocarditis, and chronic systemic illness. His contributions have saved countless young lives.

References

  • 1.   Lipshultz S.E., et al. Cardiotoxicity of cancer therapy in children. NEJM.
  • 2.   Towbin J.A., Lipshultz S.E., et al. Pediatric Cardiomyopathy Registry. J Pediatrics.
  • 3.   Lipshultz S.E., et al. HIV-related cardiomyopathy in children. Circulation.
  • 4.   Lipshultz S.E., et al. Long-term survivors of childhood cancer. Lancet Oncology.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

The authors report no conflicts of interest in this work.

About this article

Cite this article

Kasumbiwal Ajay H., Lakhe Siddheshwar A., Pavani Kaithi, et al. The Contribution of Dr. Steven E Lipshultz in Field of Pediatrics. Pediatr. Edu. Res. 2025; 13(2): 255-257.

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.

Received Accepted Published
December 11, 2025 December 31, 2025 December 31, 2025
DOI: 10.21088/per.2321.1644.13225.54

Keywords

Pediatric cardiologyCardiomyopathyHIV cardiomyopathyKawasaki diseaseChildhood heart failure

Article Level Metrics

Last Updated

Monday 07 September 2026, 04:45:38 (IST)

1862

Accesses

5
192
00

Citations


NA
NA
NA

Download citation


Article Keywords

Keyword Highlighting

Highlight selected keywords in the article text.


Timeline

Received December 11, 2025
Accepted December 31, 2025
Published December 31, 2025

licence

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article

Reprint Order Form
Buy this Article
Institutional Subscriptions

Share